143 related articles for article (PubMed ID: 20003144)
1. Attitude to extended use and long-term storage of newborn screening blood spots in Japan.
Fujii C; Sato Y; Harada S; Kakee N; Gu YH; Kato T; Shintaku H; Owada M; Hirahara F; Umehashi H; Yoshino M
Pediatr Int; 2010 Jun; 52(3):393-7. PubMed ID: 20003144
[TBL] [Abstract][Full Text] [Related]
2. Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.
Hart A; Petros M; Charrow J; Nash C; Wicklund C
J Genet Couns; 2015 Jun; 24(3):482-90. PubMed ID: 25410141
[TBL] [Abstract][Full Text] [Related]
3. Storage and use of residual dried blood spots from state newborn screening programs.
Olney RS; Moore CA; Ojodu JA; Lindegren ML; Hannon WH
J Pediatr; 2006 May; 148(5):618-22. PubMed ID: 16737872
[TBL] [Abstract][Full Text] [Related]
4. Prenatal Education of Parents About Newborn Screening and Residual Dried Blood Spots: A Randomized Clinical Trial.
Botkin JR; Rothwell E; Anderson RA; Rose NC; Dolan SM; Kuppermann M; Stark LA; Goldenberg A; Wong B
JAMA Pediatr; 2016 Jun; 170(6):543-9. PubMed ID: 27043416
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of parents of children with serious health conditions regarding residual bloodspot use.
Nagaraj CB; Rothwell E; Hart K; Latimer S; Schiffman JD; Botkin JR
Public Health Genomics; 2014; 17(3):141-8. PubMed ID: 24713606
[TBL] [Abstract][Full Text] [Related]
6. Mothers' Views on Longer Storage of Neonatal Dried Blood Spots for Specific Secondary Uses.
van Teeffelen SR; Douglas CM; van El CG; Weinreich SS; Henneman L; Radstake M; Cornel MC
Public Health Genomics; 2016; 19(1):25-33. PubMed ID: 26581038
[TBL] [Abstract][Full Text] [Related]
7. Analysis of educational materials and destruction/opt-out initiatives for storage and use of residual newborn screening samples.
Haga SB
Genet Test Mol Biomarkers; 2010 Oct; 14(5):587-92. PubMed ID: 20858049
[TBL] [Abstract][Full Text] [Related]
8. Citizens' values regarding research with stored samples from newborn screening in Canada.
Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
[TBL] [Abstract][Full Text] [Related]
9. Public attitudes regarding the use of residual newborn screening specimens for research.
Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
[TBL] [Abstract][Full Text] [Related]
10. Public and Healthcare Provider Receptivity toward the Retention of Dried Blood Spot Cards and Their Usage for Extended Genetic Testing in Hong Kong.
Belaramani KM; Fung CW; Kwok AMK; Lee SYR; Yau EKC; Luk HM; Mak CM; Yeung MCW; Ngan OMY
Int J Neonatal Screen; 2023 Aug; 9(3):. PubMed ID: 37606482
[TBL] [Abstract][Full Text] [Related]
11. Michigan BioTrust for Health: public support for using residual dried blood spot samples for health research.
Duquette D; Langbo C; Bach J; Kleyn M
Public Health Genomics; 2012; 15(3-4):146-55. PubMed ID: 22488457
[TBL] [Abstract][Full Text] [Related]
12. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
Golbahar J; Altayab DD; Carreon E
J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
[TBL] [Abstract][Full Text] [Related]
13. Effect of storage time on gene expression data acquired from unfrozen archived newborn blood spots.
Ho NT; Busik JV; Resau JH; Paneth N; Khoo SK
Mol Genet Metab; 2016 Nov; 119(3):207-213. PubMed ID: 27553879
[TBL] [Abstract][Full Text] [Related]
14. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.
Turgeon C; Magera MJ; Allard P; Tortorelli S; Gavrilov D; Oglesbee D; Raymond K; Rinaldo P; Matern D
Clin Chem; 2008 Apr; 54(4):657-64. PubMed ID: 18281422
[TBL] [Abstract][Full Text] [Related]
15. Common criteria among States for storage and use of dried blood spot specimens after newborn screening.
Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A
Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553
[TBL] [Abstract][Full Text] [Related]
16. Storage and use of residual dried blood spots.
Webster D; ;
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():49-51. PubMed ID: 15906694
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan.
Aoki K; Ohwada M; Kitagawa T
J Inherit Metab Dis; 2007 Aug; 30(4):608. PubMed ID: 17641826
[TBL] [Abstract][Full Text] [Related]
18. From newborn screening to population health research: implementation of the Michigan BioTrust for health.
Langbo C; Bach J; Kleyn M; Downes FP
Public Health Rep; 2013; 128(5):377-84. PubMed ID: 23997284
[TBL] [Abstract][Full Text] [Related]
19. Maternal attitudes and knowledge about newborn screening.
Newcomb P; True B; Walsh J; Dyson M; Lockwood S; Douglas B
MCN Am J Matern Child Nurs; 2013; 38(5):289-94; quiz 295-6. PubMed ID: 23799342
[TBL] [Abstract][Full Text] [Related]
20. Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots.
Cordovado SK; Earley MC; Hendrix M; Driscoll-Dunn R; Glass M; Mueller PW; Hannon WH
Clin Chim Acta; 2009 Apr; 402(1-2):107-13. PubMed ID: 19161996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
